CIK 0001665988
- Accelerated filer
- Emerging growth company
Bioventus Inc.
Sign in to watch- Ticker
- BVS
- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 810980861
- Phone
- +1 919-474-6700
- Business address
- 4721 EMPEROR BOULEVARD, SUITE 100, DURHAM, NC, 27703
- 4 Open-market sale Director sold 12,000 shares at $8.79 ($105,439)
- 4 Shares withheld for taxes SVP & CFO gave up 9,429 shares (to pay taxes)
- 4 Shares withheld for taxes SVP & Chief Compliance Officer gave up 2,133 shares (to pay taxes)
- 4 Shares withheld for taxes SVP & General Counsel gave up 6,327 shares (to pay taxes)
- 4 Shares withheld for taxes President and CEO gave up 41,717 shares (to pay taxes)
- 4 Open-market sale Director sold 10,000 shares at $7.57 ($75,658)
- 3 Insider Initial Statement of Ownership
- 4 Open-market sale Director sold 17,701 shares at $7.42 ($131,255)
- 4 Option exercise Director acquired 7,575 shares (option exercise)
- 4 Option exercise Director acquired 26,493 shares (option exercise)
- 4 Option exercise Director acquired 26,493 shares (option exercise)
- 4 Option exercise Director acquired 26,493 shares (option exercise)
- 4 Option exercise Director acquired 26,493 shares (option exercise)
- 4 Option exercise Director acquired 26,493 shares (option exercise)
- 4 Option exercise Director acquired 26,493 shares (option exercise)
- 4 Option exercise Director acquired 26,493 shares (option exercise)
- 4 Option exercise Director acquired 26,493 shares (option exercise)
- 4 Derivatives Options or other derivatives
- 4 Option exercise Director acquired 26,493 shares (option exercise)
- 4 Planned sale SVP & CFO sold 3,875 shares at $7.57 ($29,334)
Page 2 of 13 · 251 filings